EMC易倍官网入口 – （中国大陆）官方网站 - EMC体育
Period
Filter by
recent search
Showing: 1 – 5 of 214 stories
19 May 2026 – 1 mins read
Driven by patients, delivering on our strategy: 2025 Integrated Annual Report now available
Ipsen’s 2025 Integrated Annual report report is now available on Ipsen.com. This essential reference document brings together key information and insights into the major developments in 2025 and what lies ahead.
15 May 2026 – 1 mins read
Right medicine, right person: Jacintha Sivarajah on science with purpose
“All?medicines?have side effects, but it’s just about trying to minimize the impact?through providing the information patients?and clinicians?need or finding other ways to mitigate that impact.” — Jacintha Sivarajah?
14 May 2026 – 2 mins read
Aesthetics, built from science
Ipsen is not new to aesthetics. For more than three decades, we have been advancing neuroscience innovations across therapeutic and aesthetic indications, building deep expertise in complex biologics, rigorous clinical development and high?quality manufacturing.
23 April 2026 – 1 mins read
Strong Q1 2026 sales growth, marking a solid start to the year
Ipsen reports 22.6% sales growth at constant exchange rates in Q1 2026, reflecting balanced growth across Oncology, Rare Disease, and Neuroscience.
22 April 2026 – 2 mins read
A New Chapter for Children with?pLGG?
For?the hundreds?of?children?diagnosed?with pediatric low-grade glioma (pLGG)?across Europe each year, the journey is rarely what families expect. It is?often long,?complex, and life-altering.?However?today,?we’re?excited that the treatment landscape has progressed.??
